EVGN - Evogene Ltd.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/201512/31/2014
Total Revenue3,3816,54011,12914,511
Cost of Revenue2,8455,6398,2559,709
Gross Profit5369012,8744,802
Operating Expenses
Research Development16,98716,40514,44914,022
Selling General and Administrative5,4965,5856,3466,036
Non Recurring----
Others----
Total Operating Expenses25,32827,62929,05029,767
Operating Income or Loss-21,947-21,089-17,921-15,256
Income from Continuing Operations
Total Other Income/Expenses Net1,1201,533708726
Earnings Before Interest and Taxes-21,947-21,089-17,921-15,256
Interest Expense----
Income Before Tax-20,827-19,556-17,213-14,530
Income Tax Expense1136--
Minority Interest----
Net Income From Continuing Ops-20,838-19,592-17,213-14,530
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-20,838-19,592-17,213-14,530
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-20,838-19,592-17,213-14,530